Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASLAN001 with Paclitaxel and Carboplatin in HER2-positive Breast Cancer
NCT02396108Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Mar 2015
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of varlitinib in breast cancer and solid tumor, sponsored by National University Hospital. Primary endpoint: Pathologic complete response rate. Status: unknown.
02
Drugs
varlitinib
03
Conditions
breast cancersolid tumor
Beyond the preview
Go deeper on NCT02396108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396108.